- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To determine whether R317573, after multiple dosing over one week, reduces the intensity of an anxiogenic reaction induced by the intravenous (i.v.) administration of cholecystokinin-tetrapeptide (CCK-4).
Critère d'inclusion
- Anxiety and depression